Stock Split History
ETFs Holding MRNA »    MRNA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Moderna is a biotechnology company focusing on messenger RNA (mRNA) therapeutics and vaccines to create medicines. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of diseases. Co. is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune diseases and cardiovascular diseases. Co. has a collaboration agreement with the Institute of Life Changing Medicines to develop a mRNA therapeutic (mRNA-3351) for Crigler-Najjar Syndrome Type 1. According to our Moderna stock split history records, Moderna has had 1 split.
Moderna stock split history picture
Moderna (MRNA) has 1 split in our Moderna stock split history database. The split for MRNA took place on July 22, 2010. This was a 1 for 4 reverse split, meaning for each 4 shares of MRNA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.

When a company such as Moderna conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Moderna stock split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Moderna shares, starting with a $10,000 purchase of MRNA, presented on a split-history-adjusted basis factoring in the complete Moderna stock split history. Moderna split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/07/2018
End date: 11/25/2022
Start price/share: $18.60
End price/share: $176.40
Dividends collected/share: $0.00
Total return: 848.39%
Average Annual Total Return: 76.24%
Starting investment: $10,000.00
Ending investment: $94,842.08
Years: 3.97
Date Ratio
07/22/20101 for 4
Astrotech Corporation (ASTC)
SuperCom (SPCB)
Qualigen Therapeutics, Inc. (QLGN)
MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETNs due June 28, 2041 (OILD)
MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETNs due March 25, 2039 (NRGD)
Ebang International Holdings Inc. (EBON)
Global X Blockchain ETF (BKCH)
Global X Blockchain & Bitcoin Strategy ETF (BITS)
Global X Emerging Markets Internet & E-commerce ETF (EWEB)
Global X MSCI China Real Estate ETF (CHIR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Moderna
Moderna Insider Buying

Moderna Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.